Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harman, D. (1981) The aging process. Proc. Natl. Acad. Sci. U. S. A. 24, 7124–7128.
Curcio, C.A., Sloan, K.R., Kalina, R.E., Hendrickson, A.E. (1990) Human photoreceptor topography. J. Comp. Neurol. 292, 497–523.
Marshall, J. (1987) The ageing retina: physiology or pathology. Eye. 1, 282–95.
Curcio, C.A., Presley, J.B., Millican, C.L., Medeiros N.E. (2005) Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye. Res. 80, 761–775.
Curcio, C.A., Millican, C.L., Allen, K.A., Kalina, R.E. (1993) Aging of the human photore-ceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest. Ophthal-mol. Vis. Sci. 34, 3278–3296.
Gao, H., Hollyfield, J.G. (1992) Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 33, 1–17.
Clarke, G., Collins, R.A., Leavitt, B.R., Rews, D.F., Hayden, M.R., Lumsden, C.J., McInnes, R.R. (2000) A one-hit model of cell death in inherited neuronal degenerations. Nature. 406, 195–199.
Cideciyan, A.V., Hood, D.C., Huang, Y., Banin, E., Li, Z.Y., Stone, E.M., Milam, A.H., Jacobson S.G. (1998) Disease sequence from mutant rhodopsin allele to rod and cone pho-toreceptor degeneration in man. Proc. Natl. Acad. Sci. U. S. A. 95, 7103–718.
Hicks, D., Sahel, J. (1999) The implications of rod-dependent cone survival for basic and clinical research. Invest. Ophthalmol. Vis. Sci. 40, 3071–3074.
Petters, R.M., Alexander, C.A., Wells, K.D., Collins, E.B., Sommer J.R., Blanton, M.R., Rojas, G., Hao, Y., Flowers, W.L., Banin, E., Cideciyan, A.V., Jacobson, S.G., Wong, F. (1997) Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat. Biotechnol. 15, 965–970.
Leveillard, T., Mohand-Said, S., Lorentz, O., Hicks, D., Fintz, A.C., Clerin, E., Simonutti, M., Forster, V., Cavusoglu, N., Chalmel, F., Dolle, P., Poch, O., Lambrou, G., Sahel, J.A. (2004) Identification and characterization of rod-derived cone viability factor. Nat. Genet. 36, 755–759.
Mohand-Said, S., Hicks, D., Dreyfus, H., Sahel, J.A. (2000) Selective transplantation of rods delays cone loss in a retinitis pigmentosa model. Arch. Ophthalmol. 118, 807–811.
Mohand-Said, S., Hicks, D., Leveillard, T., Picaud, S., Porto, F., Sahel, J.A. (2001) Rod-cone interactions: developmental and clinical significance. Prog. Retin. Eye. Res. 20, 451–467.
Fintz, A.C., Audo, I., Hicks, D., Mohand-Said, S., Leveillard, T, and Sahel, J. (2003) Partial characterization of retina-derived cone neuroprotection in two culture models of photorecep-tor degeneration. Invest. Ophthalmol. Vis. Sci. 44, 818–825.
Curcio, C.A., Owsley, C., Jackson, G.R. (2000) Spare the rods, save the cones in aging and age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 41, 2015–2018.
Barron, M.J., Johnson, M.A., Rews, R.M., Clarke, M.P., Griffiths P.G., Bristow, E., He, L.P., Durham, S., Turnbull, D.M. (2001) Mitochondrial abnormalities in ageing macular photore-ceptors. Invest. Ophthalmol. Vis. Sci. 42, 3016–3022.
Winkler, B.S., Boulton, M.E., Gottsch, J.D., Sternberg, P. (1999) Oxidative damage and age-related macular degeneration. Mol. Vis. 5, 32.
Ramirez, J.M., Ramirez, A.I., Salazar, J.J., de Hoz, R., Trivino, A. (2001) Changes of astro-cytes in retinal ageing and age-related macular degeneration. Exp. Eye. Res. 73, 601–615.
Curcio, C.A., Drucker, D.N. (1993) Retinal ganglion cells in Alzheimer's disease and aging. Ann. Neurol. 33, 248–257.
Szweda, P.A., Camouse, M., Lundberg, K.C., Oberley, T.D., Szweda, L.I. (2003) Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems. Ageing Res. Rev. 2, 383–405.
Schutt, F., Davies, S., Kopitz, J., Holz, F.G., Boulton, M.E. (2000) Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest. Ophthalmol. Vis. Sci. 41, 2303–2308.
Young, R.W., Bok, D. (1969) Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell. Biol. 42, 392–403.
Katz, M.L. (2002) Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. Arch. Gerontol. Geriatr. 34, 359–370.
Holz, F.G., Schutt, F., Kopitz, J., Eldred, G.E., Kruse, F.E., Volcker, H.E., Cantz, M. (1999) Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipo-fuscin. Invest. Ophthalmol. Vis. Sci. 40, 737–743.
Bergmann, M., Schutt, F., Holz, F.G., Kopitz, J. (2004) Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 18, 562–564.
Sparrow, J.R., Nakanishi, K., Parish, C.A. (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 41, 1981–1989.
Suter, M., Reme, C., Grimm, C., Wenzel, A., Jaattela, M., Esser, P., Kociok, N., Leist, M., Richter, C. (2000) Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625–39630.
Boulton, M., Dontsov, A., Jarvis-Evans, J., Ostrovsky, M., Svistunenko, D. (1993) Lipofus-cin is a photoinducible free radical generator. J. Photochem. Photobiol. B. 19, 201–204.
Schutt, F., Bergmann, M., Holz, F.G., Kopitz, J. (2003) Proteins modified by malondialde-hyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44, 3663–3668.
Eldred, G.E., Lasky, M.R. (1993) Retinal age pigments generated by self assembling lyso-somotropic detergents. Nature. 361, 724–726.
Roth, F., Bindewald, A., Holz, F.G. (2004) Key pathophysiologic pathways in age-related macular disease. Graefes. Arch. Clin. Exp. Ophthalmol. 242, 710–716.
Kopitz, J., Holz, F.G., Kaemmerer, E., Schutt, F. (2004) Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie. 86, 825–831.
Fishkin, N., Sparrow, J.R., Allikmets, R., Nakanishi, K. (2005) Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc. Natl. Acad. Sci. U. S. A. 102, 7091–7096.
Hogan, M.J., Alvarado, J. (1967) Studies on the human macula. IV. Aging changes in Bruch's membrane. Arch. Ophthalmol. 77, 410–420.
Guymer, R., Luthert, P., Bird, A. &$$$;(1999 Changes in Bruch's membrane and related structures with age. Prog. Retin. Eye. Res. 18, 59–90.
Grindle, C.F., Marshall, J. (1978) Ageing changes in Bruch's membrane and their functional implications. Trans. Ophthalmol. Soc. U. K. 98, 172–175.
Chong, N.H., Keonin, J., Luthert, P.J., Frennesson, C.I., Weingeist, D.M., Wolf, R.L., Mullins, R.F., Hageman, G.S. (2005) Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am. J. Pathol. 166, 241–251.
Anderson, D.H., Mullins, R.F., Hageman, G.S., Johnson, L.V. (2002) A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411–431.
Johnson, L.V., Leitner, W.P., Rivest, A.J., Staples, M.K., Radeke, M.J., Anderson, D.H. (2002) The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 99, 11830–11835.
Mullins, R.F., Russell, S.R., Erson, D.H., Hageman, G.S. (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835–846.
Anderson, D.H., Talaga, K.C., Rivest, A.J., Barron, E., Hageman, G.S., Johnson, L.V. (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye. Res. 78, 243–256.
Farboud, B., Aotaki-Keen, A., Miyata, T., Hjelmeland, L.M., Handa, J.T. (1999) Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye. Mol. Vis. 5, 11.
Ishibashi, T., Murata, T., Hangai, M., Nagai, R., Horiuchi, S., Lopez, P.F., Hinton, D.R., Ryan, S.J. (1998) Advanced glycation end products in age-related macular degeneration. Arch. Ophthalmol. 116:1629–1632.
Curcio, C.A., Millican, C.L., Bailey, T., Kruth, H.S. (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42, 265–274.
Lamb, T.D., Pugh, E.N. Jr. (2004) Dark adaptation and retinoid cycle of vision. Prog. Retin. Eye. Res. 23, 307–380.
Lovie-Kitchin, J.E., Brown, B. (2000) Repeatability and intercorrelations of standard vision tests as a function of age. Optom. Vis. Sci. 77, 412–420.
Rubin, G.S., West, S.K., Munoz, B., Bandeen-Roche, K., Zeger, S., Schein, O., Fried, L.P. (1997) A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest. Ophthalmol. Vis. Sci. 38, 557–568.
Schneck, M.E., Haegerstrom-Portnoy, G., Lott, L.A., Brabyn, J.A., Gildengorin, G. (2004) Low contrast vision function predicts subsequent acuity loss in an aged population: the SKI study. Vision Res. 44, 2317–2325.
Haegerstrom-Portnoy, G., Schneck, M.E., Brabyn, J.A. (1999) Seeing into old age: vision function beyond acuity. Optom. Vis. Sci. 76, 141–158.
Guirao, A., Gonzalez, C., Redondo, M., Geraghty, E., Norrby, S., Artal, P. (1999) Average optical performance of the human eye as a function of age in a normal population. Invest. Ophthalmol. Vis. Sci. 40, 203–213.
Johnson, C.A., Adams, A.J., Lewis, R.A. (1989) Evidence for a neural basis of age-related visual field loss in normal observers. Invest. Ophthalmol. Vis. Sci. 30, 2056–2064.
Johnson, C.A., Marshall, D., Jr. (1995) Aging effects for opponent mechanisms in the central visual field. Optom. Vis. Sci. 72, 75–82.
Jackson, G.R., Owsley, C. (2000) Scotopic sensitivity during adulthood. Vision Res. 40, 2467–2473.
Jackson, G.R., Owsley, C., McGwin, G., Jr. (1999) Aging and dark adaptation. Vision Res. 39, 3975–3982.
Owsley, C., Jackson, G.R., White, M., Feist, R., Edwards, D. (2001) Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 108, 1196–1202.
Pauleikhoff, D., Chen, J.C., Chisholm, I.H., Bird, A.C. (1990) Choroidal perfusion abnormality with age-related Bruch's membrane change. Am. J. Ophthalmol. 109, 211–217.
Schefrin, B.E., Bieber, M.L., McLean, R., Werner, J.S. (1998) The area of complete sco-topic spatial summation enlarges with age. J. Opt. Soc. Am. A. Opt. Image. Sci. Vis. 15, 340–348.
Birch, D.G., Anderson, J.L. (1992) Standardized full-field electroretinography, normal values and their variation with age. Arch. Ophthalmol. 110, 1571–1576.
Weleber, R.G. (1981) The effect of age on human cone and rod ganzfeld electroretinograms. Invest. Ophthalmol. Vis. Sci. 20, 392–399.
Fortune, B., Johnson, C.A. (2002) Decline of photopic multifocal electroretinogram responses with age is due primarily to preretinal optical factors. J. Opt. Soc. Am. A. Opt. Image. Sci. Vis. 19, 173–184.
Gerth, C., Garcia, S.M., Ma, L., Keltner, J.L., Werner, J.S. (2002) Multifocal electroretino-gram: age-related changes for different luminance levels. Graefes. Arch. Clin. Exp. Ophthal-mol. 240, 202–208.
Kurtenbach, A., Weiss, M. (2002) Effect of aging on multifocal oscillatory potentials. J. Opt. Soc. Am. A. Opt. Image. Sci. Vis. 19, 190–196.
Klein, R., Klein, B.E., Linton, K.L. (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 99, 933–943.
Bird, A.C., Bressler, N.M., Bressler, S.B., Chisholm, I.H., Coscas, G., Davis, M.D., de Jong, P.T., Klaver, C.C., Klein, B.E., Klein, R., Mitchell, P., Sarks, J.P., Sarks, S.H., Soubrane, G., Taylor, H.R., Vingerling, J.R. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epi-demiological Study Group. Surv. Ophthalmol. 39, 367–374.
Whittaker, S.G., Budd, J., Cummings, R.W. (1988) Eccentric fixation with macular scotoma. Invest. Ophthalmol. Vis. Sci. 29, 268–278.
Age-Related Eye Disease Study Research Group. (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417–1436.
Evans, J.R. (2001) Risk factors for age-related macular degeneration. Prog. Retin. Eye. Res. 20, 227–53.
Grizzard, S.W., Arnett, D., Haag, S.L. (2003) Twin study of age-related macular degeneration. Ophthalmic Epidemiol. 10, 315–322.
Hammond, C.J., Webster, A.R., Snieder, H., Bird, A.C., Gilbert, C.E., Spector, T.D. (2002) Genetic influence on early age-related maculopathy: a twin study. Ophthalmology. 109, 730–736.
Sepp, T., Khan, J.C., Thurlby, D.A., Shahid, H., Clayton, D.G., Moore, A.T., Bird, A.C., Yates, J.R. (2006) Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Oph-thalmol. Vis. Sci. 47, 536–540.
Malek, G., Johnson, L.V., Mace, B.E., Saloupis, P., Schmechel, D.E., Rickman, D.W., Toth, C.A., Sullivan, P.M., Bowes Rickman, C. (2005) Apolipoprotein E allele-dependent patho-genesis: a model for age-related retinal degeneration. Proc. Natl. Acad. Sci. U. S. A. 102, 11900–11905.
Rivera, A., White, K., Stohr, H., Steiner, K., Hemmrich, N., Grimm, T., Jurklies, B., Lorenz, B., Scholl, H.P., Apfelstedt-Sylla, E., Weber, B.H. (2000) A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am. J. Hum. Genet. 67, 800–813.
Radu, R.A., Mata, N.L., Nusinowitz, S., Liu, X., Sieving, P.A., Travis, G.H. (2003) Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Star-gardt's macular degeneration. Proc. Natl. Acad. Sci. U. S. A 100, 4742–7.
Radu, R.A., Han, Y., Bui, T.V., Nusinowitz, S., Bok, D., Lichter, J., Widder, K., Travis, G.H., Mata, N.L. (2005) Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest. Ophthalmol. Vis. Sci. 46, 4393–4401.
Maiti, P., Kong, J., Kim, S.R., Sparrow, J.R., Allikmets, R., Rando, R.R. (2006) Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry. 45, 852–860.
Liu, J., Itagaki, Y., Ben-Shabat, S., Nakanashi, K., Sparrow, J.R. (2000) The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J. Biol. Chem. 275, 29354–29360.
Ben-Shabat, S., Parish, C.A., Vollmer, H.R., Itagaki, Y., Fishkin, N., Nakanishi, K., Sparrow, J.R. (2002) Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin. J. Biol. Chem. 77, 7183–7190.
Kim, S.R., Nakanishi, K., Itagaki, Y., Sparrow, J.R. (2006) Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye. Res. 82, 828–839.
Gragoudas, E.S., Adamis, A.P., Cunningham, E.T., Jr., Feinsod, M., Guyer, D.R. (2004) VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805–2816.
Heier, J.S., Antoszyk, A.N., Pavan, P.R., Leff, S.R., Rosenfeld, P.J., Ciulla, T.A., Dreyer, R.F., Gentile, R.C., Sy, J.P., Hantsbarger, G., Shams, N. (2006) Ranibizumab for treatment of neovascular age-related macular degeneration. A phase I/II multicenter, controlled, multi-dose study. Ophthalmology. 113, 642.e1–e4.
Bochow, T.W., D'Amico, D.J., Marks, B., Jerdan, J., Sullivan, E.K., Robertson, S.M., Slakter, J.S., Sullins, G., Zilliox, P., Anecortave Acetate Clinical Study Group. (2006) Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascu-larization in age-related macular degeneration. Ophthalmology. 113, 3–13.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Bellmann, C., Sahel, J.A. (2008). The Aging of the Retina. In: Tombran-Tink, J., Barnstable, C.J. (eds) Visual Transduction and Non-Visual Light Perception. Ophthalmology Research. Humana Press. https://doi.org/10.1007/978-1-59745-374-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-374-5_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-957-4
Online ISBN: 978-1-59745-374-5
eBook Packages: MedicineMedicine (R0)